Your browser doesn't support javascript.
loading
MiRNA-27a sensitizes breast cancer cells to treatment with Selective Estrogen Receptor Modulators.
Ljepoja, Bojan; García-Roman, Jonathan; Sommer, Ann-Katrin; Wagner, Ernst; Roidl, Andreas.
Affiliation
  • Ljepoja B; Pharmaceutical Biotechnology, Department of Pharmacy, Ludwig-Maximilians-Universität München, Munich, Germany.
  • García-Roman J; Pharmaceutical Biotechnology, Department of Pharmacy, Ludwig-Maximilians-Universität München, Munich, Germany.
  • Sommer AK; Pharmaceutical Biotechnology, Department of Pharmacy, Ludwig-Maximilians-Universität München, Munich, Germany.
  • Wagner E; Pharmaceutical Biotechnology, Department of Pharmacy, Ludwig-Maximilians-Universität München, Munich, Germany.
  • Roidl A; Pharmaceutical Biotechnology, Department of Pharmacy, Ludwig-Maximilians-Universität München, Munich, Germany. Electronic address: andreas.roidl@cup.uni-muenchen.de.
Breast ; 43: 31-38, 2019 Feb.
Article in En | MEDLINE | ID: mdl-30415143

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tamoxifen / Breast Neoplasms / Drug Resistance, Neoplasm / Selective Estrogen Receptor Modulators / MicroRNAs / Estrogen Receptor alpha Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Breast Journal subject: ENDOCRINOLOGIA / NEOPLASIAS Year: 2019 Document type: Article Affiliation country: Germany Country of publication: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tamoxifen / Breast Neoplasms / Drug Resistance, Neoplasm / Selective Estrogen Receptor Modulators / MicroRNAs / Estrogen Receptor alpha Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Breast Journal subject: ENDOCRINOLOGIA / NEOPLASIAS Year: 2019 Document type: Article Affiliation country: Germany Country of publication: Netherlands